Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-05-03

Clinical Trial Update: Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on ubiquinol supplementation to assist ovulation induction in clomiphene citrate–resistant PCOS, completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ubiquinol (ubiquinol)

Snippet

Sponsor: Saudi German Hospital - Madinah | Conditions: Polycystic Ovarian Syndrome | Phase 2, Phase 3 | Status: COMPLETED